• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals Inc REGN 3 Star

Last Price$513.86Day Change (%)0.34%
Open Price$512.00Day Change ($)1.72
Day Range509.45–517.1852-Week Range269.50–519.46

As of Fri 5/29/2015 11:37:00 AM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. UPDATE: Transports' death cross raises -2-

    UPDATE: Transports' death cross raises -2-

  2. Retrophin Sells FDA Voucher to Sanofi for $245 Million -- Update

    Retrophin Sells FDA Voucher to Sanofi for $245 Million -- Update

  3. Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Studies with Sarilumab in Patients with Rheumatoid Arthritis

    Regeneron and Sanofi Announce Positive Topline Results from Phase 3 Studies with Sarilumab in Patients with Rheumatoid Arthritis

  4. Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma Presented at the American Thoracic Society 2015 International Conference

    Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma Presented at the American Thoracic Society 2015 International Conference

  5. UPDATE: 10 companies with the biggest earnings -2-

    UPDATE: 10 companies with the biggest earnings -2-

  6. UPDATE: 10 companies with the biggest earnings -2-

    UPDATE: 10 companies with the biggest earnings -2-

  7. Sanofi, Regeneron Seek US Approval for Rheumatoid Arthritis Drug

    Sanofi, Regeneron Seek US Approval for Rheumatoid Arthritis Drug

  8. Research and Markets: Global Rectal Cancer Pipeline Report 2015 - 11 Companies & 12 Drug Profiles

    Research and Markets: Global Rectal Cancer Pipeline Report 2015 - 11 Companies & 12 Drug Profiles

  9. An S&P 500 breakout attempt remains in play -2-

    An S&P 500 breakout attempt remains in play -2-

  10. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.